PubRank

M W Steward

Author PubWeight™ 127.72‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The immunopathological significance of the heterogeneity of antibody affinity. Clin Exp Immunol 1971 4.67
2 Differences in immune elimination in inbred mice. The role of low affinity antibody. Clin Exp Immunol 1972 3.03
3 The use of ammonium sulphate globulin precipitation for determination of affinity of anti-protein antibodies in mouse serum. Immunology 1972 3.00
4 An inhibition enzyme immunoassay for estimating relative antibody affinity and affinity heterogeneity. J Immunol Methods 1988 2.27
5 The heterogeneity of antibody affinity in inbred mice and its possible immunopathologic significance. Clin Exp Immunol 1972 2.04
6 The importance of antibody affinity in the performance of immunoassays for antibody. J Immunol Methods 1985 1.89
7 The role of low affinity antibody in immune complex disease. The quantity of anti-DNA antibodies in NZB/W F1 hybrid mice. Clin Exp Immunol 1975 1.81
8 Changes in immunoglobulin class and subclass of anti-DNA antibodies with increasing age in N/ZBW F1 hybrid mice. Clin Exp Immunol 1976 1.77
9 The genetic control of antibody affinity in mice. Immunology 1975 1.75
10 Chronic immune complex disease in mice: the role of antibody affinity. Clin Exp Immunol 1979 1.70
11 Inter-mouse strain differences in macrophage function and its relationship to antibody responses. Clin Exp Immunol 1974 1.65
12 The antigen-binding characteristics of antibody pools of different relative affinity. Immunology 1972 1.64
13 The induction of chronic antigen-antibody complex disease in selectively bred mice producing either high or low affinity antibody to protein antigens. Immunology 1980 1.55
14 Affinity of antibody responses in man to hepatitis B vaccine determined with synthetic peptides. Lancet 1984 1.47
15 The use of a double isotope method in the determination of antibody affinity. J Immunol Methods 1973 1.45
16 Relative affinity of anti-protein antibodies in New Zealand mice. Clin Exp Immunol 1972 1.39
17 Incorporation of 5-methylorcylaldehyde and methionine into the acetogenin (polyketide) gliorosein in Gliocladium roseum I.M.I. 93065. Biochem J 1968 1.38
18 IgG subclass-associated affinity differences of specific antibodies in humans. J Immunol 1988 1.33
19 The effects of protein malnutrition on macrophage function and the amount and affinity of antibody response. Clin Exp Immunol 1974 1.33
20 Resistance of rabbit secretory IgA to proteolysis. Biochim Biophys Acta 1971 1.31
21 Macrophage clearance function and immune complex disease in New Zealand Black/White F1 hybrid mice. Clin Exp Immunol 1976 1.30
22 The measurement of antibody affinity: a comparison of five techniques utilizing a panel of monoclonal anti-DNP antibodies and the effect of high affinity antibody on the measurement of low affinity antibody. J Immunol Methods 1983 1.28
23 Failure of affinity maturation leads to increased susceptibility to immune complex glomerulonephritis. Immunology 1984 1.21
24 Prediction and identification of a T cell epitope in the fusion protein of measles virus immunodominant in mice and humans. J Gen Virol 1990 1.20
25 Experimental antigen-antibody complex disease in mice. The role of antibody levels, antibody affinity and circulating antigen-antibody complexes. Int Arch Allergy Appl Immunol 1982 1.18
26 The adjuvant effect of a non-toxic mutant of heat-labile enterotoxin of Escherichia coli for the induction of measles virus-specific CTL responses after intranasal co-immunization with a synthetic peptide. Immunology 1996 1.17
27 Measurement of antigen-antibody complexes in mouse sera by conglutinin, C1q and rheumatoid factor solid phase binding assays. J Immunol Methods 1980 1.16
28 Evidence for the genetic control of antibody affinity from breeding studies with inbred mouse strains producing high and low affinity antibody. Immunology 1976 1.15
29 The effect of malaria on the relative affinity of mouse antiprotein antibody. Br J Exp Pathol 1973 1.14
30 The genetic control of antibody affinity. Evidence from breeding studies with mice selectively bred for either high or low affinity antibody production. Immunology 1979 1.11
31 Influence of the T-helper epitope on the titre and affinity of antibodies to B-cell epitopes after co-immunization. Mol Immunol 1993 1.07
32 The affinity of IgG antibodies to gag p24 and p17 in HIV-1-infected patients correlates with disease progression. Clin Exp Immunol 1995 1.03
33 Influence of antibody affinity on the performance of different antibody assays. J Immunol Methods 1984 1.03
34 Antibody affinity and clearance function studies in high and low antibody affinity mice. The effect of protein deficiency. Immunology 1979 1.02
35 Studies on the genetic control of antibody affinity: the independent control of antibody levels and affinity in Biozzi mice. J Immunol 1976 1.01
36 Determination of the affinity of antibodies to hepatitis B surface antigen in human sera. J Immunol Methods 1984 1.01
37 Glomerulonephritis induced by pre-formed immune complexes containing monoclonal antibodies of defined affinity and isotype. Clin Exp Immunol 1984 1.00
38 Analysis of the antigenic epitopes of hepatitis B surface antigen involved in the induction of a protective antibody response. Virus Res 1992 1.00
39 Variations in host responses and the pathogenesis of human onchocerciasis. Rev Infect Dis 1986 0.98
40 Antibody responses to non-immunogenic synthetic peptides induced by co-immunization with immunogenic peptides. Immunology 1992 0.98
41 Low molecular weight mercaptoethanol sensitive antibody in rabbits. Immunochemistry 1969 0.98
42 The affinity of anti-HBc antibodies in acute and chronic hepatitis B infection. Clin Exp Immunol 1990 0.98
43 Immune responses in mice following immunization with chimeric synthetic peptides representing B and T cell epitopes of measles virus proteins. J Gen Virol 1991 0.98
44 Antibody affinity maturation in selectively bred high and low-affinity mice. Eur J Immunol 1986 0.97
45 The significance of antibody affinity heterogeneity in antigen-antibody reactions demonstrated by computer simulation. Mol Immunol 1980 0.96
46 Chronic liver disease: the detection and characterization of circulating immune complexes. Immunology 1983 0.95
47 The absence of loss of antibodies of high affinity to human immunodeficiency virus (HIV) is associated with disease progression in HIV-1-infected patients. J Infect Dis 1995 0.93
48 The binding affinities of rheumatoid factors interacting with the C gamma 3 homology region of human IgG. Clin Exp Immunol 1973 0.92
49 The effect of cyclophosphamide on the antibody response. Proc R Soc Med 1973 0.92
50 Engineering of a polymeric bacterial protein as a scaffold for the multiple display of peptides. Proteins 2004 0.91
51 Localization of covalent immune complexes on the epithelial side of the glomerular basement membrane in mice. Int Arch Allergy Appl Immunol 1984 0.91
52 Induction of measles virus-specific cytotoxic T-cell responses after intranasal immunization with synthetic peptides. Immunology 1996 0.91
53 Definition of the primary structure of hepatitis B virus (HBV) pre-S hepatocyte binding domain using random peptide libraries. Virology 1997 0.89
54 Antibody affinity maturation: the role of CD8+ cells. Clin Exp Immunol 1989 0.89
55 Circulating antigen-antibody complexes in onchocerciasis. Clin Exp Immunol 1982 0.89
56 Protection against measles virus-induced encephalitis by anti-mimotope antibodies: the role of antibody affinity. Virology 2000 0.89
57 Protection against morbillivirus-induced encephalitis by immunization with a rationally designed synthetic peptide vaccine containing B- and T-cell epitopes from the fusion protein of measles virus. J Virol 1995 0.89
58 Chronic antigen-antibody-complex glomerulonephritis in mice. Br J Exp Pathol 1981 0.88
59 Antibody responses to recombinant and plasma derived hepatitis B vaccines. Br Med J (Clin Res Ed) 1986 0.88
60 The effects of a flanking sequence on the immune response to a B and a T cell epitope from the fusion protein of measles virus. J Gen Virol 1992 0.87
61 A peptide mimic of a protective epitope of respiratory syncytial virus selected from a combinatorial library induces virus-neutralizing antibodies and reduces viral load in vivo. J Virol 1998 0.87
62 Antipeptide antibody responses following intranasal immunization: effectiveness of mucosal adjuvants. Infect Immun 2000 0.87
63 Nasal delivery of chitosan-DNA plasmid expressing epitopes of respiratory syncytial virus (RSV) induces protective CTL responses in BALB/c mice. Vaccine 2003 0.86
64 A peptidomimetic antagonist of TNF-alpha-mediated cytotoxicity identified from a phage-displayed random peptide library. J Immunol 1998 0.85
65 Experimental zinc deficiency: effects on cellular responses and the affinity of humoral antibody. Clin Exp Immunol 1989 0.85
66 Low affinity antibody--its possible immunopathologic significance. Int Arch Allergy Appl Immunol 1973 0.85
67 The potential of synthetic peptides for vaccines. Med Lab Sci 1985 0.85
68 Immunological analysis of the protective responses to the chimeric synthetic peptide representing T- and B-cell epitopes from the fusion protein of measles virus. Virus Res 1996 0.85
69 Studies on the biosynthesis of phenols in fungi. Biosynthesis of 3,4-dimethoxy-6-methyltoluquinol and gliorosein in Gliocladium roseum I.M.I. 93 065. Biochem J 1967 0.84
70 Efficient binding to the MHC class I K(d) molecule of synthetic peptides in which the anchoring position 2 does not fit the consensus motif. FEBS Lett 1996 0.84
71 Low affinity antibody production in mice - a form of immunological tolerance? Eur J Immunol 1974 0.84
72 Interferon-gamma potentiates antibody affinity in mice with a genetically controlled defect in affinity maturation. Clin Exp Immunol 1990 0.84
73 CTL responses induced by a single immunization with peptide encapsulated in biodegradable microparticles. J Immunol Methods 1997 0.83
74 HBsAg: anti-HBs immune complexes. A method for separating the constituent components and assessment of the affinity of the antibody. J Immunol Methods 1986 0.83
75 The effect of immunological adjuvants on the relative affinity of anti-protein antibodies. Immunology 1977 0.83
76 Relationship of the quality and quantity of circulating anti-BSA antibodies to the severity of glomerulonephritis in rats with chronic serum sickness. Clin Exp Immunol 1987 0.83
77 Induction of systemic immune responses to measles virus synthetic peptides administered intranasally. Vaccine 1995 0.83
78 CTL epitopes identified with a defective recombinant adenovirus expressing measles virus nucleoprotein and evaluation of their protective capacity in mice. Virus Res 1999 0.82
79 Production of anti-peptide specific antibody in mice following immunization with peptides conjugated to mannan. J Immunol Methods 1992 0.82
80 Identification of helper T cell antigenic sites in mice from the haemagglutinin glycoprotein of measles virus. J Gen Virol 1993 0.82
81 Detection of circulating antigens and immune complexes in feline and human lymphatic filariasis. Southeast Asian J Trop Med Public Health 1981 0.82
82 A surrogate hepatitis B virus antigenic epitope represented by a synthetic peptide and an internal image antiidiotype antibody. J Exp Med 1986 0.81
83 The activation of C3 and C4 in human serum by immune complexes containing mouse monoclonal antibodies of different isotype and affinity: effects on solubilisation. Mol Immunol 1988 0.81
84 Allotypic markers on rabbit IgA. Biochem Biophys Res Commun 1968 0.81
85 Immune responses and protection induced by mucosal and systemic immunisation with recombinant measles nucleoprotein in a mouse model of measles virus-induced encephalitis. Arch Virol 2001 0.81
86 Fine specificity of the antibody response to a synthetic peptide from the fusion protein and protection against measles virus-induced encephalitis in a mouse model. J Gen Virol 1997 0.80
87 Priming of measles virus-specific CTL responses after immunization with a CTL epitope linked to a fusogenic peptide. Virology 1996 0.80
88 Associations between clinical disease, circulating antibodies and C1q-binding immune complexes in human onchocerciasis. Parasite Immunol 1987 0.80
89 Comparison of three methods used for the measurement of the avidity of antibody to DNA. J Immunol Methods 1978 0.80
90 Protection against measles virus-induced encephalitis by antibodies from mice immunized intranasally with a synthetic peptide immunogen. Vaccine 1998 0.80
91 The use of synthetic peptides for analysing the specificity and affinity of anti-HBs antibodies in human sera. Ann Sclavo Collana Monogr 1984 0.80
92 Reduction of respiratory syncytial virus titer in the lungs of mice after intranasal immunization with a chimeric peptide consisting of a single CTL epitope linked to a fusion peptide. Virology 1998 0.80
93 Protective cytotoxic T lymphocyte responses against paramyxoviruses induced by epitope-based DNA vaccines: involvement of IFN-gamma. Int Immunol 1998 0.80
94 The effects of immunoglobulin isotype and antibody affinity on complement-mediated inhibition of immune precipitation and solubilization. Mol Immunol 1987 0.80
95 Analysis of the antigenic profile of measles virus haemagglutinin in mice and humans using overlapping synthetic peptides. Virus Res 1994 0.80
96 Identification of an immunodominant neutralizing and protective epitope from measles virus fusion protein by using human sera from acute infection. J Virol 1997 0.80
97 Sex-associated differences in the antibody-dependent cellular cytotoxicity antibody response to measles vaccines. Clin Diagn Lab Immunol 2000 0.80
98 Induction of cytotoxic T-cell responses following oral immunization with synthetic peptides encapsulated in PLG microparticles. J Control Release 1999 0.80
99 Mimotopes of viral antigens and biologically important molecules as candidate vaccines and potential immunotherapeutics. Comb Chem High Throughput Screen 2002 0.79
100 Peptide mimics of a conformationally constrained protective epitopes of respiratory syncytial virus fusion protein. Immunol Lett 1997 0.79
101 The potential of combinatorial peptide libraries for the identification of inhibitors of TNF-alpha mediated cytotoxicity in vitro. Immunol Lett 1997 0.79
102 The effect of antibody isotype on the activation of C3 and C4 by immune complexes formed in the presence of serum: correlation with the prevention of immune precipitation. Mol Immunol 1990 0.78
103 Immunopathological mechanisms in the induction of parasitic diseases with particular reference to type III hypersensitivity reactions. Parasitology 1987 0.78
104 Glomerulonephritis: the use of grafted hybridomas to investigate the role of epitope density, antibody affinity and antibody isotype in active serum sickness. Immunology 1984 0.78
105 Nasal delivery of epitope based vaccines. Adv Drug Deliv Rev 2001 0.78
106 Relationship of antibody affinity to onset of immune complex disease in New Zealand mice. Ann Rheum Dis 1977 0.78
107 Use of a solid-phase random peptide library to identify inhibitors of TNF-alpha mediated cytotoxicity in vitro. Cytokine 1997 0.78
108 Linkage of a fusion peptide to a CTL epitope from the nucleoprotein of measles virus enables incorporation into ISCOMs and induction of CTL responses following intranasal immunization. Vaccine 1996 0.78
109 The induction of respiratory syncytial virus-specific cytotoxic T-cell responses following immunization with a synthetic peptide containing a fusion peptide linked to a cytotoxic T lymphocyte epitope. Immunology 1995 0.78
110 Deconstructing the antigenic profile of a protective epitope from measles virus fusion protein using overlapping peptides. Vaccine 1999 0.77
111 A phage-displayed mimotope inhibits tumour necrosis factor-alpha-induced cytotoxicity more effectively than the free mimotope. Immunology 1999 0.77
112 The influence of epitope density on the estimation of the affinity of antibody for complex antigens. J Immunol Methods 1991 0.77
113 Synergistic effect of immunization with a peptide cocktail inducing antibody, helper and cytotoxic T-cell responses on protection against respiratory syncytial virus. J Gen Virol 1999 0.77
114 Oral delivery of poly(lactide-co-glycolide) encapsulated vaccines. Behring Inst Mitt 1997 0.76
115 Biodegradable microparticles as a delivery system for measles virus cytotoxic T cell epitopes. Mol Immunol 1996 0.76
116 The effect of protein deficiency on the development of chronic antigen-antibody complex disease in mice. Clin Exp Immunol 1981 0.75
117 Hepatitis B surface antigen containing immune complexes occur in seronegative hepatocellular carcinoma patients. Clin Exp Immunol 1984 0.75
118 Trypanosome infection of mice depresses antibody affinity and delays affinity maturation. Clin Exp Immunol 1983 0.75
119 Capillary-localized low-affinity antibody-antigen complexes act as a focus for the deposition of high-affinity complexes. Clin Exp Immunol 1989 0.75
120 Antibody affinity: immunogenetic aspects and relationship to immune complex disease. J Clin Pathol Suppl (R Coll Pathol) 1979 0.75
121 The potential of immunization with synthetic peptides to overcome the immunosuppressive effect of maternal anti-measles virus antibodies in young mice. Immunology 1994 0.75
122 Development of novel hepatitis B vaccines. Dev Biol Stand 1985 0.75
123 The relationship of allergic disease to immunodeficiency. Int Arch Allergy Appl Immunol 1973 0.75
124 Dissociation of primary antigen-antibody bonds is essential for complement mediated solubilization of immune precipitates. Mol Immunol 1992 0.75
125 Mucosal immunization with a measles virus CTL epitope encapsulated in biodegradable PLG microparticles. J Immunol Methods 1996 0.75
126 Proceedings: Models of immune complex diseases and the role of antibody affinity. J Clin Pathol 1976 0.75
127 Detection of rabbit allotypes by hemagglutination. Proc Soc Exp Biol Med 1969 0.75
128 Recognition of simian sarcoma virus antigen by human sera. Haematol Blood Transfus 1979 0.75
129 Circulating antibody-antigen complexes following Trypanosoma musculi infection in mice genetically selected to produce high or low affinity antibody. Parasite Immunol 1985 0.75
130 Structural properties of chimeric peptides containing a T-cell epitope linked to a fusion peptide and their importance for in vivo induction of cytotoxic T-cell responses. Eur J Biochem 1997 0.75
131 Circulating immune complexes in hepatitis B: levels, immunoglobulin class of antibody and the presence of hepatitis B surface antigen. Dev Biol Stand 1983 0.75
132 Structural requirements for synthetic immunogens to induce measles virus specific CTL responses. Mol Immunol 1996 0.75
133 The effect of Trichinella spiralis on the rate of clearance of 51Cr-labelled sheep red blood cells and 125I-polyvinyl pyrrolidone from the bloodstream of mice. J Helminthol 1981 0.75